The Set Point Is Not Where We Thought: The Primacy of Baroreflex Gain Variability

Background: For decades, cardiovascular physiology has been built on the assumption that arterial baroreceptors adjust heart rate (HR) to maintain a defined blood pressure set point. We challenge this paradigm fundamentally. Blood pressure and heart rate both change substantially in response to physiological stress and neither returns reliably to a fixed baseline value. This raises the question of whether a higher-order variable, one that remains stable while blood pressure and heart rate reset freely might better represent a truly defended, set-point quantity. Hypothesis: We hypothesized that the coefficient of variation of the instantaneous baroreceptor gain (IBS CV), expressed as the change in R-R interval per unit change in systolic blood pressure (SBP), is invariant across different physiological challenges. If IBS CV is fixed, then HR and SBP must vary proportionally, maintaining a stable gain relationship even as each changes in magnitude. Methods: To test this hypothesis, we had healthy adult volunteers undergo either the cold pressor test or passive orthostatic challenge. HR, SBP, IBS, and the coefficients of variation (CV, i.e. standard deviation / mean value) of each were measured at baseline and during each stress perturbation. Results: During orthostatic challenge, HR rose significantly while SBP fell significantly. Classically, this HR rise is attributed to baroreflex compensation for falling pressure. However, the critical observation is that SBP was not restored to baseline. Instead, it remained substantially reduced while HR stayed persistently elevated and HR CV increased significantly. A system primarily defending a blood pressure set point should augment baroreflex gain and suppress pressure variability; instead mean IBS showed no significant change, SBP CV amplified more than threefold, and IBS CV was unchanged. During the cold pressor test, both HR and SBP rose simultaneously, which is inconsistent with a pressure-defending system that would have suppressed HR in response to the large rise in SBP. IBS CV was also stable across this perturbation while SBP CV amplified dramatically. Conclusion: These findings challenge the classical baroreceptor set-point model and suggest that IBS CV, not blood pressure, is the primary regulated cardiovascular variable. Furthermore, IBS CV is likely to prove to be a more sensitive marker than blood pressure or heart rate variability for risk stratification in patients with hypertension, heart failure, or autonomic insufficiency.